01

Sub: Disclosure pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in relation to pledge of equity shares of For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: October 05, 2026

Page 1

02

Part A Annexure Disclosures under Regulation 29(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part-A- Details of the Acquisition Name of the Target Company (TC) BLISS GVS PHARMA LIMITED Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders Whether the acquirer belongs to Promoter/Promoter group No Name(s) of the Stock Exchange(s) where the shares of TC are Listed BSE Limited and National Stock Exchange of India Limited Details of the acquisition as follows Number % w.r.t.

Page 2

03

After the acquisition, holding of acquirer along with PACs of: a) Shares carrying voting rights - - - b) VRs otherwise than by equity shares - - - c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition - - - d) Shares in nature of encumbrance (pledge/lien/non-disposal undertaking/others) 5,09,84,595 47.95% 46.77% e) Total (a+b+c+d) 5,09,84,595 47.95% 46.77% Mode of acquisition (e .g.

Page 3

04

open market / public issue / rights issue / preferential allotment / inter- se transfer/ encumbrance, etc.) By way of pledge of equity shares of the Target Company in favour of Catalyst Trusteeship Limited Salient features of the securities acquired including time till redemption, ratio at which it can be converted into equity shares, etc.

Page 3

05

Pledge over 5,09,84,595 equity shares of the Target Company BLISS GVS PHARMA LIMITED in favour of Catalyst Trusteeship Limited acting as Debenture Trustee on behalf of Debenture holders. Date of acquisition of / date of receipt of intimation of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC.

Page 3